David Vigerust, MS, Ph.D of SimplyTest to Present “Saliva as the New Blood” at AAOSH Annual Session 2025

DALLAS, TX – Sept. 9, 2025 – Renowned clinical scientist David Vigerust, MS, Ph.D, will take the stage at the American Academy for Oral Systemic Health (AAOSH) Annual Session 2025 to present “Saliva as the New Blood: Redefining Diagnostics for the Oral–Systemic Era.” The session will be held at the Cooper Hotel Conference Center & Spa in Dallas, Sept. 11, 2025.

Dr. Vigerust’s session offers a groundbreaking view into the use of saliva as a frontline diagnostic tool. With today’s technology, saliva bridges a historic gap between subjective impressions and objective, actionable data for early disease detection and preventive care.

Session title: Saliva as the New Blood: Redefining Diagnostics for the Oral–Systemic Era
Date: Thursday, September 11
Time: 3:15-4:15 p.m.
Location: Cooper Hotel Conference Center & Spa- Integrative Insights Room
Speaker: David Vigerust, MS, Ph.D

This session will equip clinicians to integrate salivary diagnostics into daily practice by linking microbial, inflammatory and proteomic signals to oral–systemic risk and routine decision-making. Dr. Vigerust will review research connecting periodontal pathogens and host-response biomarkers to cardiometabolic and inflammatory disease, offering a clear path from interpretation to intervention.

Attendees will learn how to:

Distinguish key salivary biomarker categories including microbial nucleic acids, inflammatory mediators and metabolomic signatures.
Evaluate appropriate technologies such as qPCR, digital PCR, NGS, and multiplex immunoassays based on sensitivity, turnaround and cost.
Implement a sample-to-report workflow covering pre-analytical controls, lab selection, clinical communication and referral criteria.
Translate reports into targeted care plans, reduce repeat testing and define clinical outcome metrics such as hs-CRP or HbA1c change.

The Future of Diagnostics
“Saliva is no longer a passive fluid—it’s a powerful matrix for preventive health,” Dr. Vigerust said. “This session will empower dental and medical professionals alike to use it as a strategic tool for risk stratification, interdisciplinary care and measurable health outcomes.”
Clinicians will walk away ready to interpret test results, engage patients with data-driven insights, and implement diagnostic protocols that are workflow-ready and economically sustainable.

Learn more: aaosh.org/as2025

About David Vigerust
David Vigerust, MS, Ph.D, is a clinical scientist with over two decades of experience at the intersection of molecular diagnostics, infectious disease, and systemic health. He has held roles in academic research, biotechnology leadership and clinical implementation of diagnostic technologies. His passion is advancing precision preventive care across dental and medical disciplines.

About SimplyTest
SimplyTest® is redefining the starting point of care through next-generation salivary science. The SimplyTest platform delivers fast, noninvasive screenings that empower health care providers, functional medicine practitioners and dental professionals to detect microbial risks earlier, personalize treatment with precision and connect oral health to whole-body outcomes. SimplyTest goes beyond traditional testing and diagnostics. It is a provider-focused platform that transforms cutting-edge salivary science into earlier insights and more effective care pathways to unlock greater revenue potential for providers while lowering costs across the healthcare system.
To learn more, visit https://www.simplytest.solutions.